Drug Guide

Generic Name

Chlorothiazide Sodium

Brand Names Diuril

Classification

Therapeutic: Diuretic, antihypertensive

Pharmacological: Thiazide diuretic

FDA Approved Indications

Mechanism of Action

Chlorothiazide inhibits sodium reabsorption in the distal tubules of the nephron, leading to increased excretion of sodium, chloride, water, and some potassium, thereby reducing blood volume and blood pressure.

Dosage and Administration

Adult: Initial dose typically 250-500 mg once daily or in divided doses. Dose may be adjusted based on response.

Pediatric: Use is based on weight and medical condition; consult specific pediatric dosing guidelines.

Geriatric: Start with lower doses due to increased sensitivity and risk of dehydration or electrolyte imbalance.

Renal Impairment: Use with caution; dose adjustment may be necessary, and benefits should be weighed carefully.

Hepatic Impairment: Use with caution; monitor for alterations in response.

Pharmacokinetics

Absorption: Well absorbed from gastrointestinal tract.

Distribution: Bound to plasma proteins, distributed widely.

Metabolism: Not significantly metabolized.

Excretion: Primarily excreted unchanged in urine.

Half Life: Approx. 6-15 hours, varies with renal function.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

Nursing Implications

Assessment: Monitor blood pressure, electrolyte levels, renal function, hydration status.

Diagnoses:

  • Risk for electrolyte imbalance
  • Risk for hypotension
  • Fluid volume deficit

Implementation: Administer with food to decrease gastrointestinal upset, monitor electrolytes regularly, assess for signs of dehydration.

Evaluation: Assess blood pressure response, electrolyte levels; adjust dose as needed.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: None specific to this drug.

Lab Test Interference: May cause changes in serum electrolyte levels, glucose, and uric acid.

Overdose Management

Signs/Symptoms: Severe electrolyte imbalance, dehydration, hypotension, dizziness.

Treatment: Discontinue drug, provide supportive care, correct electrolyte imbalances, and maintain hydration.

Storage and Handling

Storage: Store at room temperature, 20-25°C (68-77°F).

Stability: Stable under recommended storage conditions.

This guide is for educational purposes only and is not intended for clinical use.